SCHEMBL7708465

SCHEMBL7708465

Nc1ncc(Oc2ccc(Cl)cc2Cl)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.43
HTR6 P50406 2/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 2/20 0.41
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2D6 P10635 1/20 0.38
KMT2A Q03164 1/20 0.38
DYRK3 O43781 1/20 0.38
CCNT1 O60563 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8133641 0.90 HTR3E (0.38) HTR7HTR6HTR1ADRD2ROCK2
SCHEMBL7716686 0.90 HTR3E (0.42) DRD2ROCK2ROCK1TP53LMNA
SCHEMBL7708476 0.90 ROCK2 (0.40) HTR7HTR6HTR1ADRD2ROCK2
SCHEMBL7712407 0.90 HTR1A (0.46) HTR7HTR6HTR1ADRD2ROCK2
SCHEMBL7712404 0.87 METAP1 (0.44) HTR7HTR6HTR1ADRD2ROCK2
SCHEMBL7708442 0.86 LMNA (0.45) ROCK2ROCK1TP53LMNAALDH1A1
SCHEMBL7712440 0.86 HTR7 (0.54) HTR7HTR6HTR1ADRD2HRH4
SCHEMBL7716574 0.84 KMT2A (0.53) HTR7HTR6HTR1ADRD2ROCK2
SCHEMBL7714135 0.82 PDE5A (0.41) HTR7HTR6HTR1ADRD2LMNA
SCHEMBL7713453 0.81 HTR3E (0.44) ROCK2ROCK1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed